PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Faculty of Health Sciences, University of Brasília (UNB), Brasília, District Federal, Brazil. ana-ribeiro.dantas@fiocruz.br.\', \'Center for Epidemiology and Health Surveillance, Oswaldo Cruz Foundation (FIOCRUZ), Brasília, District Federal, Brazil.\', \'Cancer Early Detection Division, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.\', \'General Coordination of Specialized Care, Health Care Secretariat, Ministry of Health (MS), Brasília, District Federal, Brazil.\', \'Department of Public Health, Faculty of Ceilândia, University of Brasília (UNB), Brasília, District Federal, Brazil.\', \'Amazon State Oncology Control Foundation (FCECON), Manaus, Amazonas, Brazil.\', \'Rutgers New Jersey Medical School (NJMS), Newark, New Jersey.\', \'Rutgers Cancer Institute of New Jersey (CINJ), New Brunswick, New Jersey.\', \'Clinical Epidemiology Unit, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1158/1940-6207.CAPR-21-0110
?:hasPublicationType
?:journal
  • Cancer prevention research (Philadelphia, Pa.)
is ?:pmid of
?:pmid
?:pmid
  • 34607876
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all